CYTH - Cassava Sciences And Alzheimer's Disease: Making Something Out Of Nothing Or Making Nothing Out Of Something
- Cassava Sciences may have removed an outlier from a previous trial in order to improve results.
- The company's drug simufilam is likely a zinc chelator; the removal of zinc has some beneficial effects for Alzheimer's patients in part because it inhibits oxidation and nitration.
- Drugs and natural products that partially reverse oxidation and nitration produce better results over longer periods of time.
For further details see:
Cassava Sciences And Alzheimer's Disease: Making Something Out Of Nothing Or Making Nothing Out Of Something